At 10.4% CAGR, the Middle East & Africa Brain Health Supplements Market is Projected to be Worth US$ 658.33 million by 2028, says The Business Market Insights

According to the Business Market Insights’ research, the Middle East & Africa brain health supplements market was valued at US$ 363.02 million in 2022 and is expected to reach US$ 658.33 million by 2028, registering a CAGR of 10.4 % from 2022 to 2028. Growing prevalence of major depressive disorders and increasing demand for brain supplements among elderly population are the critical factors attributed to the Middle East & Africa brain health supplements market expansion.                     

Depression, which is a common mental disorder, is different from normal mood fluctuations and temporary emotional responses to challenges faced every day. When depression is recurrent with moderate or severe intensity, it may become a severe health issue. It can hamper the performance of affected individuals in homes, workplaces, schools, etc. People suffering from depression are also likely to attempt suicide.

The adequate consumption of nutrients contributes to better overall health and mental health. Hence, the optimum supply of nutrients as adjunctive therapy to antidepressant treatment is essential for adequate brain functioning. Thus, the growing prevalence of major depressive disorders is driving the growth of the brain health supplements market.  

On the contrary, lack of regulations and false claims by manufacturers hurdles the growth of Middle East & Africa brain health supplements market.

Based on product, the Middle East & Africa brain health supplements market is segmented into natural molecules, herbal extract, and vitamins and minerals. The natural molecules segment held 47.7% share of Middle East & Africa brain health supplements market in 2022, amassing US$ 173.23 million. It is projected to garner US$ 308.67 million by 2028 to expand at 10.1% CAGR during 2022–2028. The natural molecules is further subsegmented into acetyl-L-carnitine, docosahexaenoic Acid (DHA), alpha GPC, citicoline, huperzine-A, and others. The herbal extract is further subsegmented into bacopa monnieri, ginkgo biloba, ginseng, curcumin, lion's mane, and others. The vitamins and minerals is further subsegmented into vitamins C and E, vitamin B complex and others.

Based on application, the Middle East & Africa brain health supplements market is segmented into memory enhancement, attention and focus, depression and mood, sleep and recovery, anti-aging and longevity, and others. The memory enhancement segment held 32.8% share of Middle East & Africa brain health supplements market in 2022, amassing US$ 119.12 million. It is projected to garner US$ 219.58 million by 2028 to expand at 10.7% CAGR during 2022–2028.  

Based on dosage form, the Middle East & Africa brain health supplements market is segmented into capsules, tablets, and others. The others segment held 45.6% share of Middle East & Africa brain health supplements market in 2022, amassing US$ 165.69 million. It is projected to garner US$ 308.91 million by 2028 to expand at 10.9% CAGR during 2022–2028.

Based on distribution channel, the Middle East & Africa brain health supplements market is segmented into supermarket and hypermarket, drug store, online and others. The supermarket and hypermarket segment held 40.1% share of Middle East & Africa brain health supplements market in 2022, amassing US$ 145.67 million. It is projected to garner US$ 267.48 million by 2028 to expand at 10.7% CAGR during 2022–2028.

Based on age category, the Middle East & Africa brain health supplements market is segmented into adults, children, and elderly. The adults segment held 44.9% share of Middle East & Africa brain health supplements market in 2022, amassing US$ 162.85 million. It is projected to garner US$ 304.50 million by 2028 to expand at 11.0% CAGR during 2022–2028.

Based on country, the Middle East & Africa brain health supplements market has been categorized into South Africa, the UAE, Saudi Arabia, and the Rest of Middle East & Africa. Our regional analysis states that South Africa captured 40.9% share of Middle East & Africa brain health supplements market in 2022. It was assessed at US$ 148.33 million in 2022 and is likely to hit US$ 271.60 million by 2028, exhibiting a CAGR of 10.6% during 2022–2028.      

Key players operating in the Middle East & Africa brain health supplements market are Teva Pharmaceutical Industries Ltd, Amway Corp, Agthia Group, and Biogen SA, among others.   

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com